This Government Contract opportunity from Department Of Defense was posted on August 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Vela Diagnostics Sequencing System for HIV-1 Genotype Testing

Closed

HT9426-26-NOI-5892Federal

Submission Closed08/27/2026, 02:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

SLED

First To Know Syphilis Tests and Controls Sets

Solicitation # QQ-130085

The Virginia Department of Health is soliciting quotes for First To Know Syphilis Tests and Controls manufactured by NowDiagnostics. The procurement includes 241 units of the Syphilis test kits (Item 8057-1-12), 145 units of the Convenience Pack (Item 8057-25-CP), and Non-assayed Syphilis Control Sets (Item 457.012). The contract is structured with four one-year renewal options, and the desired delivery time is 14 calendar days after receipt of order to a location in Henrico, Virginia. Bidders must provide a certified test report from a recognized laboratory and submit all proposals through the eVA portal. Award priority is given to DSBSD-certified micro and small businesses, including women-owned and minority-owned firms, provided the pricing is determined to be fair and reasonable. Proposals must remain valid for 90 days, and contractors are required to maintain specific insurance coverages authorized by the Virginia State Corporation Commission. Key technical requirements include the provision of Material Safety Data Sheets and adherence to strict storage protocols for control sets, which must be refrigerated at 2–8°C and not frozen. Payment is contingent upon the completion of installation, testing, and acceptance by the agency, with a standard payment term of 30 days.

Virginia Department of Health

POSTED

DEADLINE

Certified Industrial Wastewater Laboratory TestingThis subcontract opportunity is for certified industrial wastewater laboratory testing to support prime contractors on Department of Veterans Affairs Medical Center projects located in Huntington, West Virginia. The selected provider will be responsible for analyzing wastewater samples for Total Phenolics, Oil and Grease, Flashpoint, Acrolein, and a full list of Volatile Organic Compounds. All testing must be conducted using EPA analytical procedures as specified in 40 CFR Part 136, and the provider must deliver formal certified laboratory analysis reports. To be eligible, the contractor must hold a valid State of West Virginia certification for wastewater testing and possess specialized instrumentation required for VOC detection. This requirement falls under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 5. Interested parties should note the response deadline of November 16, 2026.

245-NETWORK Contract Office 5 (36C245)

POSTED

DEADLINE

Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.

Solicitation # 36C26027Q0058

The Department of Veterans Affairs, through Network Contracting Office 20, is seeking a comprehensive histology staining workflow system for the Puget Sound Health Care System in Seattle, Washington. The required system must include two immunohistochemistry and two in-situ hybridization immunostainers, two special stainers, and an integrated specimen tracking system to ensure patient safety, maintain a chain of custody, and monitor productivity. The workflow components must be fully automated, communicate with one another, and maintain compatibility with Data Innovations middleware as well as VISTA, Cerner, and any future electronic health record systems acquired by the VA. The contract follows a Cost Per Reportable Result pricing model and spans a base year from February 1, 2027, to January 31, 2028, with four subsequent one-year option periods extending through January 31, 2032. Technical requirements specify that the immunostainers must perform 100% of tests listed in the provided specifications and support simultaneous IHC, ISH, and Direct Immunofluorescence staining. Equipment must support Code 39 and Code 128 barcodes, include a safe hazardous waste removal system, and be provided with an uninterruptible power supply capable of supporting a 15-minute controlled shutdown. The contractor is responsible for the delivery, installation, and removal of equipment at no additional charge and must guarantee a minimum equipment uptime of 98%. Performance and method validation must adhere to CLSI guidelines and College of American Pathologists standards. Additionally, the contractor must comply with strict federal and VA information security directives, including those regarding data confidentiality and media sanitization. Emergency supply orders must be fulfilled within 24 hours of a verbal request, providing enough consumables for one week of normal operation.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Army Medical Resources Acquisition Activity is soliciting a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1. To maintain FDA approval and operational requirements, the contractor must provide original manufacturer-supplied consumables, as no generic substitutes are available. Required supplies include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, and ACD-A Solution. The contract is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS code 325413. The BPA features a cumulative ceiling not to exceed 350,000 dollars over a 60-month ordering period, with individual call orders typically having a 12-month period of performance. Award will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as either acceptable or unacceptable. Offerors must submit a two-volume quote by October 29, 2026, using the mandatory Exhibit A Pricing Sheet. Delivery is FOB Destination to Fort Sam Houston, Texas, and invoicing must be processed through the Wide Area WorkFlow system.

Army Medical Resources Acq Activity

POSTED

DEADLINE

6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES

Solicitation # 36C26227Q0046

The Department of Veterans Affairs, Network Contracting Office 22, is conducting a sources sought notice for the procurement of FDA approved reagents, supplies, consumables, and quality control materials for Werfen Hemochron Signature Elite instruments. This requirement supports the Pathology and Laboratory Medicine Service at the Southern Arizona VA Health Care System in Tucson, Arizona. The contract structure includes a base year from January 1, 2027, to December 31, 2028, followed by four subsequent option years extending through December 31, 2032. The selected contractor must provide 24/7 technical and product support at no additional cost and ensure all items are fully compatible with existing instrumentation without requiring workflow changes or retraining. Key operational requirements include strict adherence to manufacturer specifications for packaging and temperature control during transport. All supplied materials must maintain a minimum shelf life of 90 days, and shipments must clearly list lot numbers and expiration dates. Standard orders are required to be delivered within four working days, while emergency deliveries for defective or temperature-compromised items must be completed within 24 hours of a verbal order. This procurement is conducted as a brand name or equal acquisition under FAR 52.211-6. Interested respondents must provide their business size status, SAM.gov identifiers, and evidence of compliance with the Buy American Act and the Non-Manufacturer Rule.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Solicitation # 2139989

The New York State Office of Mental Health, specifically for the Nathan S. Kline Institute in Rockland, has established a single-source procurement exemption to add drug abuse testing commodities to an existing contract. This action integrates tests previously purchased on a discretionary basis, adding a total of 185,000.00 dollars over three years, which averages 61,500.00 dollars annually. The procurement includes specific laboratory calibrators and controls, such as Syva Creatinine Validity Calibrators in various concentrations, Syva Validity Negative Calibrators, and EMIT Calibrators/Controls at levels 2 and 5. The contract term is effective from May 1, 2024, through April 30, 2029, with the agency planning to re-procure these services around the fall of 2028. Ron Foster, Contract Management Specialist 2, serves as the primary point of contact for this agreement. This procurement was processed as an exemption from advertising to ensure the necessary testing materials are formally incorporated into the agency's contractual framework.

NYS Office of Mental Health

POSTED

DEADLINE

Cepheid Reagents & Supplies for GeneXpert Testing Platform

Solicitation # 2140004

The State University of New York, specifically SUNY Stony Brook University Hospital, has issued solicitation number 2140004 for the procurement of Cepheid Reagents and Supplies for the GeneXpert Testing Platform. This procurement is categorized under Medical and Health Care Commodities and is designated as a sole or single source procurement exempt from advertising. The request was formally approved by the Office of the State Comptroller on October 14, 2026, under NYS Contract Reporter Exemption Request SNY01-0004719-3320215 (CRER-0469C). The contract term is established from October 13, 2025, through October 12, 2027, with the place of performance located at Stony Brook University Hospital state-wide. The primary point of contact for this action is Zhong Yi Hu. The notice was posted on October 16, 2026, with an advertisement end date of October 23, 2026. No specific contract value or pricing details were provided in the documentation.

State University of New York (SUNY)

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-0714

Solicitation SPE2DS-27-T-0714 is issued by the Defense Logistics Agency for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2 and 30 degrees Celsius and must have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of order, with the FOB and inspection/acceptance points set to destination. The contractor must adhere to Medical Marking Standard No. 1 for all labeling, ensuring the inclusion of the contract or lot number and the manufacture, expiration, or retest date. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers in accordance with DLA packaging requirements and MIL-STD-2073-1E. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American and Balance of Payments Program. The solicitation is categorized under NAICS code 325413 and incorporates various FAR and DFARS clauses regarding cybersecurity, safeguarding covered defense information, and the HUBZone price evaluation preference.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Antibody Identification Panel CellsThis subcontract involves the manufacture and delivery of antibody identification panel cells for prime contractors supporting Department of Veterans Affairs Network Contract Office 20 medical supply projects. These red blood cell reagents are critical for matching donated blood products to recipients within Surgery, Oncology, Emergency, and Medical Units, with shipments specifically destined for the Boise VA Medical Center. The provider must maintain strict compliance with clinical standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract is managed by the Department of Veterans Affairs with performance associated with the Vancouver area.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Supply of Quality Control Check CellsThis subcontract involves the manufacture and delivery of specialized red blood cell quality control check cells for the Department of Veterans Affairs Network Contract Office 20. These reagents are critical for validating patient testing within the Transfusion Services Department and are delivered specifically to the Boise VA Medical Center. The provider must maintain strict quality control standards and hold Federal Supply Schedule status under Group 66 III Cat 605-2A. Operating under NAICS code 325413, the contract ensures that prime contractors on medical supply projects have the necessary materials to maintain clinical accuracy and regulatory compliance.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

Q301--VA Boise, Idaho - Blood Bank Reagents Requirement

Solicitation # 36C26027Q0082

The Department of Veterans Affairs, through Network Contracting Office 20, has issued a pre-solicitation notice for the procurement of red blood cell reagents to support the Transfusion Services Department at the Boise, Idaho VA Medical Center. This requirement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing. The scope of work involves the supply of quality control check cells and antibody identification panel cells that adhere to strict quality control and compliance standards for patient testing. These reagents are critical for matching donated blood products to recipients in various hospital departments, including Surgery, Oncology, Emergency, and Medical Units. This notice is intended for market research and planning purposes and does not constitute a formal Request for Quotation or a commitment to contract. Interested parties must submit a response by October 26, 2026, at 16:00 PT to Contract Specialist Andrew O'Neal. Required submissions include company contact information, DUNS number, business size and socioeconomic status, a statement regarding Federal Supply Schedule status under Group 66 III Cat 605-2A, and a capability statement not exceeding three pages demonstrating the necessary resources, personnel, and experience to fulfill the requirement.

260-NETWORK Contract Office 20 (36C260)

POSTED

DEADLINE

KKH_KRFP261018_Medsupplies_Detection of DNA of BV and CV associated pathogens and TV kit with Free on Loan Equipment

Solicitation # Doc2439781197

KK Women’s and Children’s Hospital, through contracting agent ALPS Pte Ltd, is seeking proposals for the supply of detection kits for DNA of BV and CV associated pathogens and TV, including free on loan equipment. This term contract spans an initial five years with an option to extend for an additional three years. Eligible participants must be locally registered companies, and those providing medical devices must hold GDPMDS certification and ensure all devices are registered with the Health Science Authority of Singapore. The scope of supply includes delivery for consumables, as well as delivery, installation, integration, testing, and commissioning for any equipment provided. Interested vendors must submit their entire response via Ariba Sourcing between October 16, 2026, and October 30, 2026, at 3:00pm Singapore Time. Submissions through other channels may lead to disqualification, and suppliers are encouraged to use generic company email addresses for all event notifications.

ALPS Pte. Ltd.

POSTED

6 days ago

DEADLINE

in 9 days

AI Contract Overview

The Defense Health Agency Contracting Activity, on behalf of the Walter Reed Army Institute of Research, intends to award a firm fixed price sole source contract to Vela Diagnostics, USA INC. This procurement is for the Sentosa SQ Next Generation Sequencing system and associated reagents, consumables, and maintenance required for FDA approved HIV-1 genotype testing. This testing is critical for monitoring drug resistance mutations in HIV-1 infected soldiers and their beneficiaries within a CAP accredited laboratory. The government has identified Vela Diagnostics as the only responsible source capable of meeting these requirements due to the FDA approval of the system and the necessity of a reagent rental agreement, which third party vendors are not authorized to provide. While this is a notice of intent to sole source, the government will consider capability statements from other vendors until August 27, 2026, to determine if a competitive procurement is in the best interest of the government.

General Info

Sole source contract for Vela Diagnostics to provide HIV-1 testing systems and reagents.

Agency

Department Of Defense → Army Medical Resources Acq Activity

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Silver Spring, MD, 20910, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed

PostedAug 12

special-notice

Response DeadlineAug 27

Deadline has passed

Submission Closed

08/27/2026, 02:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Army Medical Resources Acq Activity

Contacts2 people available

OfficeFORT DETRICK, MD, 21702, USA

Organization / AgencyDepartment Of Defense → Army Medical Resources Acq Activity

Office AddressFORT DETRICK, MD, 21702, USA

Contacts

Brenda Mena

contact@example.gov

Lance Nowell

contact@example.gov

Full Description

Notice of Intent (NOI) to Sole Source

Title: Vela Sentosa SQ Next Generation Sequencing (NGS) for FDA Approved HIV-1 Genotype Sequencing

Requiring Activity: Walter Reed Army Institute of Research (WRAIR) , Diagnostics and Countermeasures Branch (DCB)

Related Notice: HT9426-26-RFI-5892

Product Service Code (PSC): 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

North American Industry Classification System (NAICS) Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Small Business Size Standard: 1250 employees

The Defense Health Agency Contracting Activity (DHACA) on behalf of the Diagnostics and Countermeasures Branch (DCB) at the Walter Reed Army Institute of Research (WRAIR) intends to award a Firm Fixed Price contract on a sole source basis to Vela Diagnostics, USA INC; 353C US Highway 46; STE 250; Fairfield, New Jersey 07004; Cage Code 86YT5 under the RFO FAR 6.103-1 – Only one responsible source can supply the required products, and no other type of supplies or services will satisfy requirements.

Description of Services: Via a reagent rental agreement, the contractor shall provide all Sentosa sequencer kits, consumables, supplies, sequencing systems and sub-components, and maintenance and repair. The HIV Diagnostics and Reference Lab (HDRL), DCB at the WRAIR currently utilizes the Sentosa SQ Next Generation Sequencing (NGS) system in order to perform HIV genotype testing which is critical for the monitoring of drug resistance mutations in HIV-1 infected soldiers and their beneficiaries. The Sentosa NGS system includes instrumentation and reagents required to perform the Vela Sentosa SQ HIV-1 Genotype test in a College of American Pathologist (CAP) accredited laboratory. As the system and assay is Food and Drug Administration (FDA) approved, clinical testing laboratories are required to use the instruments and reagents approved by the FDA in the execution of the test. Market Research was conducted and indicated similar products from other companies cannot meet or be modified to meet the Government’s requirements. Additionally, this contract requires a reagent rental agreement between the manufacturer and the Government. Vela has confirmed that authorized third party vendors of Vela products are not authorized to offer this agreement; ergo, the requirements of this contract can only be met by Vela.

This special notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government.

If no meaningful, written submissions are received by the date listed below, after the publication of this notice, the solicitation will be issued as a sole source requirement to Vela Diagnostics, USA INC. Based on the above information, the only technically acceptable vendor to fulfill this requirement is Vela Diagnostics, USA INC.

Submit capability statements (using PDF, MS Word, or Excel attachments) to Ms. Brenda Mena at e-mail: brenda.i.mena.civ@health.mil.

Capability statements are due no later than 10:00am Eastern Daylight Time on 27 August 2026. No phone calls will be accepted